🎯 check Lanifibranor (IVA-337) product page
Lanifibranor (IVA-337) is a potent pan-PPAR (PPARα, PPARγ, and PPARδ) agonist. It affects PPAR and lipid metabolism signaling by activating all three PPAR isotypes to modulate target gene transcription, effectively reducing hepatic steatosis, inflammation, and fibrosis.